In8bio
INAB

In8bio (INAB) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$1.24
EPS estimate
−$1.73
Revenue
$0.00
Reported
Aug 7, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 7, 2025−$1.73−$1.24+28.12%$0.00SEC
Q1 2025May 7, 2025−$2.03−$2.10−3.70%$0.00SEC
Q4 2024Mar 13, 2025−$2.15−$2.40−11.63%$0.00SEC
Q3 2024Nov 12, 2024−$5.10−$4.50+11.76%$0.00SEC
Q2 2024Aug 8, 2024−$5.20−$5.70−9.62%$0.00SEC
Q1 2024May 9, 2024−$5.04−$6.00−19.05%$0.00SEC
Q4 2023Mar 14, 2024−$4.60−$6.60−43.48%$0.00SEC
Q3 2023Nov 9, 2023−$7.35−$6.90+6.12%$0.00SEC
Q2 2023Aug 10, 2023−$8.10−$8.10+0.00%$0.00SEC
Q1 2023May 12, 2023−$9.60−$9.00+6.25%$0.00SEC
Q4 2022Mar 30, 2023−$9.50−$9.60−1.05%$0.00SEC
Q3 2022Nov 10, 2022−$8.80−$10.20−15.91%$0.00SEC
Q2 2022Aug 12, 2022−$8.70−$11.40−31.03%$0.00SEC
Q1 2022May 12, 2022−$9.90−$9.90+0.00%$0.00SEC
Q4 2021Mar 17, 2022−$7.95−$13.20−66.04%$0.00SEC
Q3 2021Nov 10, 2021−$8.25−$7.50+9.09%$0.00SEC

Quarterly revenue

Q3 2021
$0.00
Q4 2021
$0.00
Q1 2022
$0.00
Q2 2022
$0.00
Q3 2022
$0.00
Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$0.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00

Frequently asked questions

  • When did In8bio (INAB) last report earnings?

    In8bio last reported on Aug 7, 2025, covering fiscal Q2 2025.

  • Did INAB beat earnings estimates?

    Yes. In8bio reported EPS of −$1.24 for Q2 2025 against a −$1.73 estimate — a 28.12% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.